The Promise in the Technology and the Data of the LOTUS Valve Insight to Secondgeneration Valve Technology and the REPRISE Trials - Ian Meredith AM, MBBS, BsC, PhD, FSCAI

↳ This is a section part of Moment: CRT 2016 Coronary - Transformative Technology May Improve Clinical Outcomes

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$6.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

The Promise in the Technology and the Data of the LOTUS Valve Insight to Secondgeneration Valve Technology and the REPRISE Trials presented by Ian Meredith AM, MBBS, BsC, PhD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$6.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Supported by an educational grant from Boston Scientific Corporation

Session Name: Transformative Technology May Improve Clinical Outcomes

Track: Coronary

Learning Objectives

Update on Complex PCI, TAVI/R & Technology

Other Components in this Moment

Overview

A Complex PCI with Synergy Stent - John Wang, MD, MSc, FSCAI

DES Evolution from First Generation to Third Generation DES with Biodegradable Polymers - Dean Kereiakes, MD, FACC, FSCAI

The Promise in the Technology and the Data of the LOTUS Valve Insight to Secondgeneration Valve Technology and the REPRISE Trials - Ian Meredith AM, MBBS, BsC, PhD, FSCAI

Reducing Stroke in Patients with AF: Paradigm Shift with LAA Closure What Does the Future Hold? - Sameer Gafoor, MD, FSCAI